Skip to content

Effect of epinephrine on perfusion index during ultrasound guided supraclavicular brachial plexus block: A randomized controlled trial

Effect of epinephrine on perfusion index during ultrasound guided supraclavicular brachial plexus block: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003006
Enrollment
82
Registered
2018-07-20
Start date
2018-07-23
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients over 19 years of age (American society of anesthesiologists class (ASA class) I, II, ? ) -With going to get parental consent if aged 70 years or older

Exclusion criteria

Exclusion criteria: pediatrics under 19 years of age Patients American society of anesthesiologists class IV or higher Patients with a BMI greater than 30 diabetes Peripheral obstructive blood vessel disease Patients with heart disease (myocardial infarction, heart failure, arrhythmia) Who is taking a / ß blocker pregnant woman Patients who are allergic to local anesthetics Patients taking anticoagulants and medications inappropriate for site anesthesia Patients with skin infections to be treated with square braces Chronic pain disorder Patients with severe lung disease Peripheral neuropathy of the arm undergoing neurological deficit or square brachial blockade

Design outcomes

Primary

MeasureTime frame
The perfusion index ratio (PI ratio) difference was assessed 10 minutes after completing supraclavicular brachial plexus block (BPB) with 12.5 ml of 0.75% ropivacaine and 12.5 ml of 2% lidocaine with 5 mcg / ml of epinephrine .

Secondary

MeasureTime frame
? Cutoff value of perfusion index with or without addition of epinephrine

Countries

Korea, Republic of

Contacts

Public ContactDoyeon Kim

Samsung Medical Center

kimdoyeon31@gmail.com+82-2-3410-2470

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 18, 2026